Ethical Promotional Activities

We believe that promotional activities are necessary to ensure for people to know and enjoy the value of our products. We at the Kyowa Kirin Group have established the "Kyowa Kirin Group Promotion Policy" to fulfill our management philosophy, and strive for ethical promotional activities as a company engaged in business deeply involved in people's lives and health.

Kyowa Kirin Group Promotion Policy

Established on August 31, 2018
Revised on June 1, 2020

We at the Kyowa Kirin Group (hereafter, referred to as "Our Group") consider promotion to be an important activity from the standpoint of letting the people of the world know the value of the Group's products and giving them the opportunity to experience the value. Promotion must never be performed by inappropriate methods or to obtain undue profit.

As a group of corporations involved in a business that is deeply invested in people's lives and health, the Group engages in ethical promotion with healthcare professionals to provide timely and truthful information that is scientifically and clinically significant when marketing our products.

"promotion" means any activity undertaken, organized or sponsored by a member company which is directed at HCPs to promote the prescription, recommendation, supply, administration or consumption of its pharmaceutical product(s) through all channels of communications .

  1. 1.
    Communication with healthcare professionals
    We will communicate with healthcare professionals aiming to benefit patients and enhance the practice of medicine, by focusing on providing valid scientific and educational information.
  2. 2.
    Independence of healthcare professionals
    We will not provide and offer gifts, financial gain and/or benefits (e.g. scholarships, grants, consultant contracts, travel and accommodation upgrade, etc.) to healthcare professionals in exchange for the prescription, recommendation, purchase, administration of our medicinal products or the promise to continue these practices or as a reward for these practices in the past. We will not provide or offer any information in a manner or under conditions that may improperly affect the prescribing practices of healthcare professionals.
  3. 3.
    Proper use of drugs
    We will promote the proper use of pharmaceuticals in an accurate, fair and balanced manner by presenting the characteristics of pharmaceuticals objectively and without exaggeration.
  4. 4.
    National regulations of each country
    We will abide by any applicable laws to laws, guidelines and industry rules on promotion in the countries and regions where our group operates. We will follow the IFPMA codes when conducting activities in countries or regions that do not have proper laws and regulations or industry codes.
  5. 5.
    Organization
    We will establish and operate appropriate organizational structures and business processes that comply with laws and regulations and industry codes in countries and regions where we operate.

System

Kyowa Kirin has a system in place to provide appropriate information on pharmaceuticals.

Before providing healthcare professionals and patients with information materials*1 on Kyowa Kirin's pharmaceuticals in Japan, we inspect the materials to check whether they fulfill the guidelines on activities to provide sales information on prescription drugs (hereinafter, the “Guidelines”)*2, as well as the standards required by relevant organizations, including the Japan Pharmaceutical Manufacturers Association. The inspection is performed by the supervisory department (CSR Management Department) and a third-party organization.

To meet the Guidelines, we have put in place the committee for supervision of activities to provide sales information on prescription drugs, whose members include third parties. The supervisory department reports to the committee on the situation regarding the supervision of and guidance for departments and staff members that provide marketing information on ethical drugs, as well as on the inspection implemented on information materials, and also seeks advice.

  • *1
    Materials pertaining to Kyowa Kirin's pharmaceuticals and related fields that are used for the purpose of providing information to healthcare professionals, patients, patients groups or the general public.
  • *2
    The guidelines are aimed at improving public health by properly conducting advertising or advertising like behaviors in the activities to provide sales information.

Training Programs

To ensure ethical promotional activities, we offer training programs on related laws and other topics for employees engaged in promotional activities.

Major training programs

  • Training for acquiring knowledge of how to create information materials in compliance with laws and regulations (For staff in charge of material creation)
  • Training for better understanding CSR and the Guidelines
    (For employees engaged in promotional activities)
  • Training aimed at widely disseminating the Guidelines among employees (For all employees in japan)